Immuneering treatment of pancreatic cancer granted FDA orphan status
The Fly

Immuneering treatment of pancreatic cancer granted FDA orphan status

Immuneering’s treatment of pancreatic cancer was granted FDA orphan designation, according to a post to the agency’s website.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App